Literature DB >> 1898408

Effect of hyperbaric oxygenation on macrophage function in mice.

Y Inamoto1, F Okuno, K Saito, Y Tanaka, K Watanabe, I Morimoto, U Yamashita, S Eto.   

Abstract

Hyperbaric oxygenation (HBO) has an immunosuppressive effect. The possible mechanisms of this immunosuppressive effect were assessed by determining the production of interleukin-1 (IL-1), interleukin-6 (IL-6), and prostaglandin E2 (PGE2), as well as phagocytosis by splenic macrophages from HBO-treated mice. Although HBO treatment did not have any significant effect on IL-6 production and phagocytotic activity, a marked decrease in IL-1 production and a significant decrease in PGE2 production were observed. These results suggest that the reduction of IL-1 production may play an important role in the immunosuppressive effect of HBO.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898408     DOI: 10.1016/0006-291x(91)91901-n

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Hyperbaric oxygenation ameliorates indomethacin-induced enteropathy in rats by modulating TNF-alpha and IL-1beta production.

Authors:  Z Yang; J Nandi; J Wang; G Bosco; M Gregory; C Chung; Y Xie; X Yang; E M Camporesi
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

2.  Hyperbaric oxygen protects mandibular condylar chondrocytes from interleukin-1β-induced apoptosis via the PI3K/AKT signaling pathway.

Authors:  Hang Chen; Gaoyi Wu; Qi Sun; Yabing Dong; Huaqiang Zhao
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

3.  Early hyperbaric oxygen therapy improves survival in a model of severe sepsis.

Authors:  Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

4.  Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease.

Authors:  G Weisz; A Lavy; Y Adir; Y Melamed; D Rubin; S Eidelman; S Pollack
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

5.  Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages.

Authors:  R M Benson; L M Minter; B A Osborne; E V Granowitz
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages.

Authors:  N Lahat; H Bitterman; N Yaniv; A Kinarty; N Bitterman
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

7.  Human amniotic fluid mesenchymal stem cells in combination with hyperbaric oxygen augment peripheral nerve regeneration.

Authors:  Hung-Chuan Pan; Chun-Shih Chin; Dar-Yu Yang; Shu-Peng Ho; Chung-Jung Chen; Shiaw-Min Hwang; Ming-Hong Chang; Fu-Chou Cheng
Journal:  Neurochem Res       Date:  2009-01-17       Impact factor: 3.996

8.  Hyperbaric oxygen treatment in autism spectrum disorders.

Authors:  Daniel A Rossignol; James J Bradstreet; Kyle Van Dyke; Cindy Schneider; Stuart H Freedenfeld; Nancy O'Hara; Stephanie Cave; Julie A Buckley; Elizabeth A Mumper; Richard E Frye
Journal:  Med Gas Res       Date:  2012-06-15

9.  Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.

Authors:  Daniel A Rossignol
Journal:  Med Gas Res       Date:  2012-03-15

10.  Laparoscopic Nissen fundoplication: The effects of high-concentration supplemental perioperative oxygen on the inflammatory and immune response: A randomised controlled trial.

Authors:  Mario Schietroma; Sara Colozzi; Beatrice Pessia; Francesco Carlei; Marino Di Furia; Gianfranco Amicucci
Journal:  J Minim Access Surg       Date:  2018 Jul-Sep       Impact factor: 1.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.